Approval · Notice of Compliance 4586 · 1996
NU-NORTRIPTYLINE: Notice of Compliance 4586
Issued June 7, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4586
- Date
- June 7, 1996
- Company
- Nu-Pharm IncVaughan, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antidepressant
- Canadian reference product
- AVENTYL (Eli Lilly Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NU-NORTRIPTYLINE | 02223139 | Approved |
| NU-NORTRIPTYLINE | 02223147 | Approved |
Medicinal ingredients
- NORTRIPTYLINE HCL 10 MG per CAP
- NORTRIPTYLINE HCL 25 MG per CAP